Clik here to view.
Medtronic fires new salvo in ongoing aortic valve patent war with Edwards
In the latest round of an ongoing patent war, Medtronic sues Edwards Lifesciences on allegations that the Sapien transcatheter aortic valve implantation system infringes 2 patents. Medtronic...
View ArticleClik here to view.
Medtronic warns on battery defect in EnTrust, Escudo ICDs
Medtronic warns that a small number of EnTrust and Escudo implantable cardioverter defibrillators may have defective battery components. Medtronic released warnings that a limited number of its...
View ArticleClik here to view.
The hack-able body: Are device makers doing enough to shield patients from...
The threat that the fusion of humans and medical machines may leave patients vulnerable to the hackers and bugs of the digital world is beginning to resonate with device makers. Karen Sandler was 31...
View ArticleClik here to view.
AGFA Gevaert slides to Q4, 2011 red | Earnings Roundup
AGFA Gevaert slides to Q4, 2011 red AGFA Gevaert (EBR:AGFB) swung to red ink for the 4th quarter and 2011. News Well, MassDevice Earnings Roundup, Q4read more
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for March 7, 2012.
Zimmer axes jobs ahead of the med-tech tax, MassDevice investigates the rising clamor around hacking medical devices and St. Jude recovers from what 1 analyst deemed a "Greek tragedy." Say hello to...
View ArticleClik here to view.
Diabetes: Yale and Medistem partner on Type I diabetes stem cell treatment |...
Medistem and Yale joined forces on a Type I diabetes treatment venture using stem cells to generate pancreatic islets, which have effectively treated diabetes in animal models. MASSDEVICE ON CALL —...
View ArticleClik here to view.
AdvaMed 2012 is on the prowl for panel ideas
AdvaMed wants to hear what medical device makers want to know and want to share at its annual med-tech conference in Boston. AdvaMed is looking for a few good ideas. With its annual conference just 7...
View ArticleClik here to view.
Covidien launches Halo60 ablation system for treatment of Barrett's esophagus
Covidien launches its latest catheter-based ablation system, Halo60, which it acquired with its buyout of Barrx Medical in November 2011. Covidien (NYSE:COV) hailed the launch of its Halo60 ablation...
View ArticleClik here to view.
Covidien beefs up R&D, aims for 50 new products over 2 years
Covidien drops $40 million on new research & development efforts, launching 4 new R&D centers with 50 new labs as it aims to release 50 new products in 2 years. Covidien (NYSE:COV) said it...
View ArticleClik here to view.
Piper Jaffray: Abiomed wins reimbursement code | Wall Street Beat
Abiomed (NSDQ:ABMD) is slated to win a reimbursement code for procedures involving its Impella heart pump, according to analysts at Piper Jaffray. In a summary of recent editorial panel decisions, the...
View ArticleClik here to view.
FDA to begin collecting data for med-tech shortage database | Regulatory Roundup
The MassDevice.com Regulatory Roundup: FDA clearances, approvals, European CE mark approvals and reimbursement wins for medical device makers. FDA plans med-tech shortage database News Well,...
View ArticleClik here to view.
Allezoe Medical says executive wrote affidavit for lawsuit opponent |...
Allezoe Medical Holdings says a board member and its corporate secretary broke company rules and maybe also state and federal laws when he wrote an affidavit supporting the plaintiff in a lawsuit...
View ArticleClik here to view.
Inside the FDA: Keeping the focus on scientific integrity
By: Jesse L. Goodman, M.D., M.P.H. Science, both its quality and its integrity, is key to everything we do at FDA. As a physician and researcher, science has always been central to the decisions I...
View ArticleClik here to view.
BoSci acquires maker of world's only lead-less ICD in a deal worth up to $1.35B
Boston Scientific exercised its option to acquire Cameron Health, maker of the only subcutaneous implantable cardioverter defibrillator commercially available anywhere in the world, in a deal worth up...
View ArticleClik here to view.
The power of observational studies
By Merrill Goozner My colleage Gary Schwitzer at HealthNewsReview.org has a post today questioning the validity of observational studies (where epidemiological researchers look at selected variables in...
View ArticleClik here to view.
Study: Heart hole closure no better than meds for preventing stroke |...
An international study concludes that a catheter-based procedure to close a hole in the heart may be no better at preventing recurrent strokes than medication alone. MASSDEVICE ON CALL — A...
View ArticleClik here to view.
Standard & Poor's gives Medtronic an A+ | Wall Street Beat
Standard & Poor's gives Medtronic's long-term debt an "A+" rating; also, ICU Medical to re-state financials; Zynex details NeuroDyne buyout terms; GI Dynamics dips on huge volume; Report: JPMorgan...
View ArticleClik here to view.
Sorin's 2011 sales stay flat, profits soar
Sorin Group (BIT:SRN) reported flat sales but strong profit growth for 2011, saying it raised earnings by 48.3%, also revealing that the cardiac rhythm management slump has made its way across the...
View ArticleClik here to view.
Ex-J&J CEO Weldon to walk with $143.5M in retirement | Personnel Moves
Outgoing Johnson & Johnson CEO William Weldon will walk with more than $143 million in retirement benefits after his 40-year tenure at the company ends in April. Outgoing Johnson & Johnson...
View ArticleClik here to view.
Medtronic wins Canadian approval for brain-stim therapy for epileptics |...
The MassDevice.com Regulatory Roundup: FDA clearances, approvals, European CE mark approvals and reimbursement wins for medical device makers. Medtronic wins Canadian approval for brain-stim epilepsy...
View Article
